BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

390 related articles for article (PubMed ID: 20860231)

  • 1. Extra-intestinal Hodgkin's lymphoma in a Crohn's disease patient on long-term azathioprine and infliximab therapy.
    Dahhan T; Al Kahtani K; Bakshi N; Abouzied ME; Helmy A
    Trop Gastroenterol; 2010; 31(1):51-3. PubMed ID: 20860231
    [No Abstract]   [Full Text] [Related]  

  • 2. Pneumocystis jiroveci (carinii) pneumonia after initiation of infliximab and azathioprine therapy in a patient with Crohn's disease.
    Seddik M; Melliez H; Seguy D; Viget N; Cortot A; Colombel JF
    Inflamm Bowel Dis; 2005 Jun; 11(6):618-20. PubMed ID: 15905713
    [No Abstract]   [Full Text] [Related]  

  • 3. Infliximab, azathioprine, or combination therapy for Crohn's disease.
    Colombel JF; Sandborn WJ; Reinisch W; Mantzaris GJ; Kornbluth A; Rachmilewitz D; Lichtiger S; D'Haens G; Diamond RH; Broussard DL; Tang KL; van der Woude CJ; Rutgeerts P;
    N Engl J Med; 2010 Apr; 362(15):1383-95. PubMed ID: 20393175
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Steroid-independent Crohn's disease patients also benefit from combination therapy of infliximab plus azathioprine.
    van den Brande JM; Peppelenbosch MP; Hommes DW
    Gastroenterology; 2006 Oct; 131(4):1362-3. PubMed ID: 17030216
    [No Abstract]   [Full Text] [Related]  

  • 5. Combining infliximab with 6-mercaptopurine/azathioprine for fistula therapy in Crohn's disease.
    Ochsenkühn T; Göke B; Sackmann M
    Am J Gastroenterol; 2002 Aug; 97(8):2022-5. PubMed ID: 12190171
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pneumocystis jiroveci (carinii) pneumonia following initiation of infliximab and azathioprine therapy in a patient with Crohn's disease.
    Seddik M; Meliez H; Seguy D; Viget N; Cortot A; Colombel JF
    Inflamm Bowel Dis; 2004 Jul; 10(4):436-7. PubMed ID: 15475754
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Hodgkin's lymphoma in a patient with Crohn's disease treated with azathioprine and antibodies anti tumor necrosis factor α].
    Sagüés M; Navarro JT; Ribera JM; Millá F
    Med Clin (Barc); 2012 Apr; 138(8):366-7. PubMed ID: 21752407
    [No Abstract]   [Full Text] [Related]  

  • 8. Infliximab and/or azathioprine in the treatment of Crohn's disease-like complications after IPAA.
    Haveran LA; Sehgal R; Poritz LS; McKenna KJ; Stewart DB; Koltun WA
    Dis Colon Rectum; 2011 Jan; 54(1):15-20. PubMed ID: 21160308
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mucosal healing with methotrexate in Crohn's disease: a prospective comparative study with azathioprine and infliximab.
    Laharie D; Reffet A; Belleannée G; Chabrun E; Subtil C; Razaire S; Capdepont M; de Lédinghen V
    Aliment Pharmacol Ther; 2011 Mar; 33(6):714-21. PubMed ID: 21235604
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mucormycosis in a Crohn's disease patient treated with infliximab.
    Wall GC; Leman BI
    Digestion; 2009; 80(3):182-4. PubMed ID: 19776582
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Infliximab heals intestinal inflammatory lesions and restores growth in children with Crohn's disease.
    Borrelli O; Bascietto C; Viola F; Bueno de Mesquita M; Barbato M; Mancini V; Bosco S; Cucchiara S
    Dig Liver Dis; 2004 May; 36(5):342-7. PubMed ID: 15191204
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Infliximab: lifetime use for maintenance is appropriate in Crohn's Disease. CON: "lifetime use" is an awfully long time.
    Loftus EV
    Am J Gastroenterol; 2005 Jul; 100(7):1435-8. PubMed ID: 15984960
    [No Abstract]   [Full Text] [Related]  

  • 13. Histoplasma epiglottitis in a patient with Crohn's disease maintained on infliximab, prednisone, and azathioprine.
    Abou Zahr A; Saad Aldin E; Yunyongying P
    Int J Infect Dis; 2013 Aug; 17(8):e650-2. PubMed ID: 23769453
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of immunogenicity on the long-term efficacy of infliximab in Crohn's disease.
    Baert F; Noman M; Vermeire S; Van Assche G; D' Haens G; Carbonez A; Rutgeerts P
    N Engl J Med; 2003 Feb; 348(7):601-8. PubMed ID: 12584368
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatocellular carcinoma occurring in a patient with Crohn's disease treated with both azathioprine and infliximab.
    Chen SC; Cummings OW; Hartley MP; Filomena CA; Cho WK
    Dig Dis Sci; 2006 May; 51(5):952-5. PubMed ID: 16670938
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Drug therapy of Crohn disease].
    Niemelä S
    Duodecim; 2001; 117(8):807-14. PubMed ID: 12116446
    [No Abstract]   [Full Text] [Related]  

  • 17. Complications of infliximab therapy in children and adolescents affected by Crohn's disease.
    Diamanti A; Papadatou B; Knafelz D; Gambarara M; Ferretti F; Castro M
    Am J Gastroenterol; 2003 Dec; 98(12):2812-3. PubMed ID: 14687847
    [No Abstract]   [Full Text] [Related]  

  • 18. Infliximab in the treatment of Crohn's disease: a user's guide for clinicians.
    Sandborn WJ; Hanauer SB
    Am J Gastroenterol; 2002 Dec; 97(12):2962-72. PubMed ID: 12492177
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Balancing the risks and benefits of prolonged use of infliximab.
    Schölmerich J
    Gut; 2009 Apr; 58(4):477-8. PubMed ID: 19299379
    [No Abstract]   [Full Text] [Related]  

  • 20. [Cytomegalovirus primary infection in a patient with Crohn's disease treated with azathioprine and anti-TNF alpha].
    Ben Hriz F; Habbessi H; Maamouri N; Belkahla N; Ouerdiane S; Chouaib S; Ouerghi H; Chaabouni H; Ben Mami N
    Tunis Med; 2009 Aug; 87(8):545-6. PubMed ID: 20180364
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 20.